On page 7 and 18 they say targeting Nerve Conduit FDA application for Q4 2025
On page 8, they say Q1 2026.
Weird.
- Forums
- ASX - By Stock
- RNV
- Ann: ReNerve - Investor Presentation
RNV
renerve limited
Add to My Watchlist
0.00%
!
10.0¢

Ann: ReNerve - Investor Presentation, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.02M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 10.0¢ | $15 | 146 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5676 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5676 | 0.105 |
2 | 5043 | 0.100 |
2 | 56000 | 0.099 |
2 | 59600 | 0.096 |
6 | 235026 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 50000 | 1 |
0.115 | 30667 | 1 |
0.120 | 146000 | 4 |
0.125 | 15000 | 1 |
0.130 | 180000 | 1 |
Last trade - 09.59am 28/07/2025 (20 minute delay) ? |
Featured News
RNV (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online